DOI:
10.1055/s-00000070
Seminars in Musculoskeletal Radiology
LinksClose Window
References
van der Heijde D, Schiff MH, Sieper J. , et al; ATLAS Study Group.
Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial.
Ann Rheum Dis 2009;
68 (06) 922-929
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.